The nurse has reviewed today's Vital Signs and Provider's Orders

Select the 2 findings that indicate an improvement in the adolescent's condition.

A. Avoid attempting to distract the client away from the hallucination: While it is important not to reinforce hallucinations, gentle redirection or distraction can help the client focus on reality and reduce distress. Avoiding all attempts at distraction may increase anxiety or withdrawal.

B. Encourage group activities: Clients actively experiencing hallucinations may have difficulty concentrating or interacting safely in a group setting. Encouraging participation at this time could increase agitation or confusion. Individualized, low-stimulation interventions are preferable.

C. Provide low lighting in the client's room: Low, soft lighting reduces environmental stimuli that can exacerbate hallucinations or agitation. Creating a calm, quiet environment supports reality orientation and helps the client manage sensory overload.

D. Use touch to convey acceptance: Physical touch may startle, confuse, or distress a client experiencing hallucinations. Safety and personal boundaries should be maintained, and touch should generally be avoided unless the client initiates or clearly consents.

A. "Albuterol treatments can cause blood glucose levels to decrease.": Albuterol is a beta-2 agonist that can actually cause mild hyperglycemia by stimulating glycogenolysis, not hypoglycemia. It is not the primary reason for routine glucose monitoring in this client.

B. "Older adults are at risk for developing type 1 diabetes mellitus.": Type 1 diabetes typically develops in childhood or adolescence and is not age-related. Older adults are more at risk for type 2 diabetes, making this statement inaccurate.

C. "Having COPD causes blood glucose levels to fluctuate.": COPD itself does not directly cause significant changes in blood glucose. Fluctuations are usually related to medications, stress, or comorbid conditions, not the pulmonary disease itself.

D. "Prednisone can cause blood glucose levels to increase.": Corticosteroids like prednisone promote gluconeogenesis and reduce peripheral glucose uptake, leading to hyperglycemia. Monitoring blood glucose in clients receiving prednisone is important to detect and manage steroid-induced elevations.